<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03088280</url>
  </required_header>
  <id_info>
    <org_study_id>01</org_study_id>
    <nct_id>NCT03088280</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Rabbit Antithymocyte Globulin 3mg/kg in Kidney Transplant Patients Under Steroid-free and CNI Minimization Maintenance Immunosuppressive Regimen</brief_title>
  <official_title>Prospective Randomized Study to Evaluate the Efficacy and Safety of Rabbit Antithymocyte Globulin 3mg/kg vs. 6mg/kg in Kidney Transplant Patients Under Steroid-free and CNI Minimization Maintenance Immunosuppressive Regimen</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Geral de Fortaleza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Geral de Fortaleza</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single-center, prospective, randomized, open-label clinical trial to evaluate the 1-year
      efficacy and safety of rATG 3mg/kg compared to 6mg/kg in low to moderate immunological risk
      patients receiving low exposure tacrolimus plus everolimus (EVL) in a steroid-free protocol.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 30, 2015</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acute rejection</measure>
    <time_frame>1 year</time_frame>
    <description>Biopsy proven and all treated acute rejection episodes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infection</measure>
    <time_frame>1 year</time_frame>
    <description>All infections requiring hospitalization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Thymoglobulin Dose</condition>
  <arm_group>
    <arm_group_label>3mg/kg Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will received Thymoglobuline 3mg/Kg (reduced dose)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6mg/kg Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will received Thymoglobuline 6mg/Kg (standard dose)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Thymoglobulin</intervention_name>
    <description>reduced dose (3mg/Kg)</description>
    <arm_group_label>3mg/kg Group</arm_group_label>
    <arm_group_label>6mg/kg Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary kidney transplant recipients, adults

        Exclusion Criteria:

          -  PRA &gt; 50%

          -  DSA &gt; 1500 MFI

          -  Retransplantation

          -  Patients who are planning to receive mycophenolate instead of everolimus

          -  Patients who have planning for follow-up in another center
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tain치 Freitas, MD, PhD</last_name>
    <phone>55 85 31013306</phone>
    <email>taina.sandes@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ronaldo Esmeraldo, MD</last_name>
    <phone>55 85 31013306</phone>
    <email>ronaldo.esmeraldo@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Transplant ward of the Hospital do Fortaleza</name>
      <address>
        <city>Fortaleza</city>
        <state>Cear치</state>
        <zip>60175-205</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tain치 Freitas, MD PhD</last_name>
      <phone>55 85 31013306</phone>
      <email>taina.sandes@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ronaldo Esmeraldo, MD</last_name>
      <phone>55 85 31013306</phone>
      <email>ronaldo.esmeraldo@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2017</study_first_submitted>
  <study_first_submitted_qc>March 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2017</study_first_posted>
  <last_update_submitted>March 17, 2017</last_update_submitted>
  <last_update_submitted_qc>March 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Geral de Fortaleza</investigator_affiliation>
    <investigator_full_name>Tain치 Veras de Sandes Freitas</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Immunosuppressive Agents</mesh_term>
    <mesh_term>Thymoglobulin</mesh_term>
    <mesh_term>Antilymphocyte Serum</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>patient data are confidential e will not be share with other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

